Skip to main content

Dilation clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • MydCombi on Pupillary Dilation in Pediatric and Adult Patients

    Sorry, not yet accepting patients

    To raise the standard of care, improve the overall patient experience and streamline practice flow, Eyenovia has developed an innovative mydriatic to be delivered as a microdose by a specialized dispenser. While still achieving effective pupil dilation, MydCombi has the potential to increase patient throughput at practicing offices by decreasing time spent eye dropping patients, eliminating time wasted waiting between drop instillations and ensuring more accurate drug delivery. The proposed study hopes to demonstrate the non-inferiority of using MydCombi to achieve pupillary dilation in patients compared to standard of care eye drops.

    San Francisco, California

Our lead scientists for Dilation research studies include .

Last updated: